Oslo, Norway – October 29, 2024 – IDEX Biometrics has appointed Kristian Flaten as Chief Financial Officer, effective November 1, 2024. Kristian Flaten brings over 25 years of financial leadership and experience with international business and financing, including from Asian growth markets, a strong focus for IDEX Biometrics. He has a proven track record in corporate finance, debt financing and business development in growth companies.  Kristian has a background as CFO with Quantafuel ASA, recycling plastic ...

Oslo, Norway – 29 October 2024 - IDEX Biometrics ASA’s interim report for the third quarter is attached to this notice (link below). The interim report is also available on the IDEX Biometrics website: www.idexbiometrics.com/investors/interim-results/ A webcast presentation of the interim report will be held by Catharina Eklof, Chief Executive Officer, today at 09:00 CET. The webcast presentation is attached to this notice (link below), and can be viewed at the following link: https://idexbiometrics.video ...

IDEX Corporation (IEX) is scheduled to release third-quarter 2024 results on Oct. 29, after market close. The Zacks Consensus Estimate for earnings has remained steady in the past 60 days. The company has an impressive earnings surprise history, having outperformed the consensus estimate in each of the preceding four quarters, the average surprise being 5.9%. The consensus estimate for revenues is pegged at $791 million, indicating a decline of 0.3% from the prior-year quarter's figure. The consensus estima ...

Reference is made to the notice on 9 October 2024 regarding issue of Tranche 2 shares and the warrants of the private placement completed on 16 September 2024. The private placement consisted of two tranches, with total gross proceeds amounting to NOK 70 million. The share capital increase related to the Tranche 2 shares has been registered and the shares will be delivered soonest. The Tranche 2 shares will be delivered on a separate and non-tradable ISIN, pending publication by the Company of a prospectus ...

IDEX Biometrics ASA held an extraordinary general meeting on 9 October 2024. 112.2 million shares or 25.47% of the share capital was represented at the meeting. All proposals on the agenda were adopted in accordance with the proposals of the Company's board of directors, including the approval of Tranche 2 of the private placement, the subsequent offering and the warrants issuance, all as announced on 17 September 2024. For further information contact: Marianne Bøe, Head of Investor Relations E-mail: ir@ide ...

Reference is made to the notice on 25 September 2024 regarding issue of Tranche 1 shares of the private placement completed on 16 September 2024. The private placement consisted of two tranches, with total gross proceeds amounting to NOK 70 million. The share capital increase related to the Tranche 1 shares has been registered and the shares will be delivered soonest. The Tranche 1 shares will be delivered on a separate and non-tradable ISIN, pending publication by the Company of a prospectus approved by th ...

Reference is made to the announcement by IDEX Biometrics ASA (the "Company") on 17 September 2024 regarding the private placement of shares with gross proceeds of NOK 70 million (the "Private Placement"). The Company retained Arctic Securities AS as sole manager and bookrunner for the Private Placement (the "Manager"). The Private Placement is divided into two tranches. 101,624,966 shares were allocated in the first tranche ("Tranche 1" and the "Tranche 1 Offer Shares") and 365,041,700 Offer Shares were all ...

IDEX Biometrics ASA held an extraordinary general meeting on 23 September 2024. 87.2 million shares or 25.7% of the share capital was represented at the meeting. The authorisation to the board to issue new shares, was approved by the extraordinary general meeting. The board will apply this authorization to issue the Tranche 1 Shares as disclosed in connection with the private placement on 16 September 2024: https://newsweb.oslobors.no/message/627919 . For the avoidance of doubt, the issue of Tranche 2 Share ...

Correction: Replaced attachment. IDEX Biometrics ASA will hold an extraordinary general meeting on Wednesday 9 October 2024 at 12.00 hours CET as an online meeting. There is no physical attendance option. Shareholders may attend online. by PC, smartphone or tablet. Reference is made to the private placement of shares on 16 September 2024, disclosed to the market on that date. The board proposes that the shareholders shall approve issue of Tranche 2 shares, a subsequent repair offering, issue of Warrants, an ...

IDEX Biometrics ASA will hold an extraordinary general meeting on Wednesday 9 October 2024 at 12.00 hours CET as an online meeting. There is no physical attendance option. Shareholders may attend online. by PC, smartphone or tablet. Reference is made to the private placement of shares on 16 September 2024, disclosed to the market on that date. The board proposes that the shareholders shall approve issue of Tranche 2 shares, a subsequent repair offering, issue of Warrants, and authorise the board to issue sh ...